CognitiveNot approvedEvidence tier: Animal Only

FGL Peptide (NCAM-derived)

Last updated October 21, 2026. Approval line checked October 21, 2026. No compounding source date is assigned.

FDA status

Not approved

Not approved. This record is not an FDA-approved drug product. Approval, where it exists, is specific to a drug product, indication, and route.

FDA: Unapproved drugs

Evidence tier

Animal Only. The tier is the highest indexed study type. It is not a safety rating and it is not an FDA approval. Confidence score 2/5. 12 PubMed citations indexed.

FGL Peptide (NCAM-derived) in the literature

FGL (FG Loop) is a 15-amino-acid peptide derived from the second fibronectin type III module of the Neural Cell Adhesion Molecule (NCAM) that activates fibroblast growth factor receptor 1 (FGFR1) sign

What the literature studies

Cognitive Research

Evidence tier

Animal Only

Compounding record

Status not verified

Confidence
2/5

Regulatory record

Status not verified. No product-specific FDA primary source is recorded for this entry. FDA approval and compounding eligibility are not verified. Research information is not evidence of FDA approval. Approval, where applicable, is specific to a drug product, indication and route. Research information is not evidence of FDA approval. Approval, where applicable, is specific to a drug product, indication and route.

Regulatory source not verified; no checked date is assigned.

No human safety, pharmacokinetic, or efficacy data exist; all evidence is limited to rodent and in vitro models.

Questions

Educational only. Not medical advice. This page does not give doses or sourcing. See the medical and editorial disclaimer.